Medical
Advent, Avista near deal for UCB's Kremers Urban
A consortium of buyout firms Advent International Corp and Avista Capital Partners is in advanced talks to acquire UCB SA's (UCB.BR) U.S. generic drugs unit Kremers Urban Pharmaceuticals Inc, according to people familiar with the matter.
Shire CFO to leave drugmaker as AbbVie drops bid
British drugmaker Shire (SHP.L) will lose its interim chief financial officer early next year to water supplier Severn Trent (SVT.L), the latest blow for Shire, whose proposed $55-billion acquisition by U.S. rival AbbVie (ABBV.N) was aborted last week.
Investors eye third quarter medical use from hospitals, insurers
Hospitals and insurers are expected to give their clearest view yet on whether people are having more surgeries and other medical procedures during the next few weeks when they report earnings, according to investors who are closely watching U.S. medical services use.
ConvaTec owners appoint banks to explore sale
ConvaTec's owners have appointed Morgan Stanley (MS.N) and Goldman Sachs (GS.N) to explore a sale of the medical device maker which could be worth up to $10 billion, sources familiar with the matter said.